Sawgrass Asset Management LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 7.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,390 shares of the company’s stock after selling 465 shares during the period. Sawgrass Asset Management LLC’s holdings in Cardinal Health were worth $420,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Bronfman E.L. Rothschild L.P. increased its position in Cardinal Health by 31.8% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after buying an additional 382 shares in the last quarter. JFS Wealth Advisors LLC boosted its stake in Cardinal Health by 14.3% during the 2nd quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock valued at $152,000 after purchasing an additional 244 shares during the last quarter. Dupont Capital Management Corp acquired a new position in Cardinal Health during the 2nd quarter valued at about $164,000. First Personal Financial Services boosted its stake in Cardinal Health by 127.5% during the 2nd quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after purchasing an additional 1,238 shares during the last quarter. Finally, Alpha Windward LLC boosted its stake in Cardinal Health by 0.7% during the 2nd quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock valued at $179,000 after purchasing an additional 17 shares during the last quarter. 87.63% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/09/23/cardinal-health-inc-cah-shares-sold-by-sawgrass-asset-management-llc.html.

Cardinal Health, Inc. (NYSE:CAH) opened at 66.66 on Friday. Cardinal Health, Inc. has a 52 week low of $62.70 and a 52 week high of $84.88. The stock has a 50 day moving average price of $67.69 and a 200-day moving average price of $74.72. The stock has a market cap of $21.09 billion, a P/E ratio of 16.54 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion during the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.14 earnings per share. On average, equities analysts anticipate that Cardinal Health, Inc. will post $4.96 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Monday, October 2nd will be given a dividend of $0.4624 per share. This represents a $1.85 annualized dividend and a dividend yield of 2.77%. The ex-dividend date is Friday, September 29th. Cardinal Health’s dividend payout ratio (DPR) is currently 45.79%.

A number of equities analysts have issued reports on the company. BidaskClub downgraded Cardinal Health from a “hold” rating to a “sell” rating in a research note on Friday, August 4th. Credit Suisse Group cut their price target on Cardinal Health from $87.00 to $81.00 and set an “outperform” rating for the company in a research note on Thursday, August 3rd. Royal Bank Of Canada assumed coverage on Cardinal Health in a research note on Tuesday. They set a “sector perform” rating and a $72.00 price target for the company. UBS AG reiterated a “neutral” rating and set a $76.00 price target (down previously from $79.00) on shares of Cardinal Health in a research note on Wednesday, August 9th. Finally, Robert W. Baird reiterated a “hold” rating and set a $73.00 price target on shares of Cardinal Health in a research note on Sunday, September 17th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company. Cardinal Health currently has an average rating of “Hold” and a consensus price target of $76.81.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.